Juan Monsalvo

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals is a worldwide, integrated, and innovation-driven organization with a presence across geographies, committed to enriching lives worldwide. Innovation is deeply embedded in Glenmark's culture; it is how we differentiate ourselves in our key markets and create great value for our stakeholders. Over the last 45 years, we have journeyed along the high road to innovation, evolving from a generics company to an innovation-driven, integrated, global pharmaceutical company. We have established a strong global Branded Generics, Generics, Specialty, and OTC business and have established a significant presence in the therapy areas of dermatology, respiratory medicine, and oncology. Our generics business serves over 80 countries, while our API business sells products in over 65 countries worldwide. Our 14 state-of-the-art manufacturing facilities and 4 R&D centres help us create breakthrough therapies for the global patient population while our global team of 15,000+ employees, including 1,400+ employees in research and development, is committed to enriching lives around the world. Glenmark's core values of Achievement, Respect and Knowledge impart a sense of organizational unity that drives our growth. As part of our CSR commitment, we have positively impacted the lives of over 2.6 million people, with a particular focus on child and maternal health. The Joy of Giving program has seen over 62,400 hours of voluntary service from our employees in over 33 countries.